Table 2. Bone Mineral Density Assessment.
| Statements | Level of Evidence* | Median Response | n/N (%)1 |
|---|---|---|---|
| Bone health needs to be considered early on in life and the following routine risk factors should be assessed: | |||
| Ability to walk | 2 | Strongly Agree | 32/33 (97.0) |
| Presence of either the p.R168X, p.R255X, p.R270X or p.T158M mutation | 2 | Strongly Agree | 28/31 (90.3) |
| Prescribed anticonvulsant medication(s) | 2 | Strongly Agree | 32/33 (97.0) |
| Oral and intramuscular progesterone medication(s) | 2 | Agree | 31/32 (96.9) |
| In the presence of risk factors, a baseline bone mineral density measurement should be performed | 4 | Agree | 32/33 (97.0) |
| Consider using the following techniques to assess bone health: | |||
| Densitometry (DXA) | 4 | Strongly Agree | 25/25 (100) |
| Lateral spine X-ray | 4 | Neither Agree or Disagree | 20/25 (80.0) |
| Peripheral quantitative computed tomography (pQCT) | 4 | Neither Agree or Disagree | 23/25 (92.0) |
| Monitor bone mineral density every 1–2 years depending on clinical presentation | 4 | Agree | 29/34 (85.3) |
| If long bone was fractured, the bone mineral density should be measured in the alternate bone | 4 | Agree | 2327 (85.2 |
| If a vertebrae was fractured, the bone mineral density may be measured in adjacent vertebrae excluding measurement of the fractured vertebrae | 4 | Agree | 25/27 (92.6) |
*Scottish Intercollegiate Guidelines network
1Numerator is the number of responses with median response or 1 category either side and denominator is the number of clinicians in the panel whose expertise were relevant to this item